Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-03-20
2011-10-18
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253010, C514S254020, C514S254030, C514S254050, C514S255010, C540S575000, C544S360000, C544S367000, C544S368000, C544S369000, C544S379000, C544S387000, C544S371000, C544S121000, C544S383000
Reexamination Certificate
active
08039463
ABSTRACT:
The present invention relates to piperazine derivatives that act as inhibitors of stearoyl-CoA desaturase. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.
REFERENCES:
patent: 5846514 (1998-12-01), Foster et al.
patent: 6334997 (2002-01-01), Foster et al.
patent: 2006/0241121 (2006-10-01), Greenlee et al.
patent: 2006/0252767 (2006-11-01), Sviridov et al.
patent: 0433662 (1991-06-01), None
patent: WO0162954 (2001-08-01), None
patent: WO0226944 (2002-04-01), None
Dobrzyn et al.Drug Discovery Today: Therapeutic Strategies, vol. 2, p. 125-128 (2005).
Vippagunta et al Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
International Search Report for PCT/US2009/037807, mailed Jul. 2, 2009.
Written Opinion of the International Searching Authority for PCT/US2009/037807, mailed Jul. 2, 2009.
Dobrzyn, Agnieszka, et al., Inhibition of Stearoyl-CoA Desaturase by Cyclic Amine Derivatives, Expert Opin. Ther. Patents, 18(4):457-460, 2008.
Xin, Zhili, et al., Discovery of Piperidine-aryl Urea-based Stearoyl-CoA Desaturase 1 Inhibitors, Bioorganic & Medicinal Chemistry Letters 18, 4298-4302, 2008.
Dean, D., Editor, Recent Advances in the Synthesis and Applications of Radiolabeled Compounds for Drug Discovery and Development, vol. 6, No. 10, pp. i-i(1), 2000.
Lindqvuist, Y., et al., Crystal Structure of Δ9 Stearoyl-acyl Carrier Protein Desaturase From Castor Seed and its Relationship to Other Di-iron Proteins, The EMBO Journal, vol. 15, No. 16, pp. 4081-4092, 1996.
de Antueno, RJ, et al., Relationship Between Mouse Liver Delta 9 Desaturase Activity and Plasma Lipds, Lipids, vol. 28, No. 4, pp. 285-290, 1993.
Kabalka, GW, The Synthesis of Radiolabeled Compounds via Organometallic Intermediates, Tetrahedron, vol. 45, No. 21, pp. 6601-6621, 1989.
Jeffcoat, R., et al., Numa, S., Editor, The Regulation of Desaturation and Elongation of Fatty Acids in Mammals, Fatty Acid Metabolism and its Regulation, pp. 84-112, 1984.
Evans, EA, Synthesis of Radiolabelled Compounds, Journal of Radioanalytical and Nuclear Chemistry, vol. 64, Nos. 1-2, pp. 9-32, 1981.
Bischoff Alexander
Prabhu Ganesh
Raikar Sandeep N.
Sammeta Srinivasa Raju
Subramanya Hosahalli
Bernhardt Emily
Charles Ryan; Michael Ciraolo; and Hemant Khanna
Forest Laboratories Holdings Limited
LandOfFree
Piperazine derivatives as inhibitors of stearoyl-CoA desaturase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine derivatives as inhibitors of stearoyl-CoA desaturase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives as inhibitors of stearoyl-CoA desaturase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4294320